Phase 2 Gastroesophageal Junction (GEJ) Adenocarcinoma Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma
Gastroesophageal Junction (GEJ) Adenocarcinoma
National Cancer Center Hospital East26 enrolled1 locationNCT07018570
Recruiting
Phase 2
Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Ruijin Hospital30 enrolled1 locationNCT07026149